SAA and CRP are potential indicators in distinction and severity assessment for children with influenza

Seyin Zou1, Jinjie Liu2, Zhiyong Yang1

  • 1Department of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou 510317, China.

Insights

Serum amyloid A (SAA) and C-reactive protein (CRP) show promise in distinguishing severe from non-severe influenza in children. Age is a key factor for accurate assessment in influenza B cases.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Biomarkers
  • Influenza Pathophysiology

Background:

  • Influenza is a significant respiratory illness in children.
  • Distinguishing severe from non-severe influenza cases is crucial for timely treatment.
  • Clinical utility of C-reactive protein (CRP) and serum amyloid A (SAA) for severity assessment in pediatric influenza is not well-established.

Purpose of the Study:

  • To evaluate the clinical value of CRP and SAA in differentiating non-severe from severe influenza in children.
  • To compare the diagnostic performance of CRP and SAA, individually and in combination, for pediatric influenza.
  • To investigate the influence of influenza type (A vs. B) on biomarker levels and severity.

Main Methods:

  • Retrospective analysis of baseline characteristics and laboratory results from pediatric influenza patients.
  • Receiver operating characteristic (ROC) curve analysis for evaluating combined diagnostic accuracy of biomarkers.
  • Scatter-dot plots to compare differences in laboratory markers between non-severe and severe influenza groups.

Main Results:

  • Influenza B was associated with higher rates of bronchitis and pneumonia; Influenza A with other serious symptoms.
  • Significant differences in lymphocyte count, neutrophil count, neutrophil-to-lymphocyte ratio (NLR), CRP, and SAA were observed between influenza A and B.
  • Combined detection of SAA with other indicators improved differentiation of influenza from healthy children.
  • Elevated CRP and SAA levels were found in severe influenza B, and elevated SAA in severe influenza A, compared to non-severe cases.

Conclusions:

  • SAA and CRP are potential biomarkers for distinguishing influenza severity in children.
  • Age adjustment is necessary when utilizing SAA and CRP for severity assessment in pediatric influenza B.
  • Further research is warranted to validate these findings and establish clinical guidelines.
Abstract